Analysts have been eager to weigh in on the Materials sector with new ratings on Albemarle (ALB – Research Report) and Cemex SAB (CX – Research Report). Albemarle (ALB) In a report released yesterday, Aleksey Yefremov from KeyBanc maintained a Sell rating on Albemarle, with a price target of $131.00. The company's shares closed last Monday at $214.16. According to TipRanks.com, Yefremov is a 4-star analyst with an average return of 15.3% and a 62.5% success rate. Yefremov covers the Basic Materials sector, focusing on stocks such as DuPont de Nemours, Eastman Chemical, and Huntsman. Currently, the analyst consensus on Albemarle is a Moderate Buy with an average price target of $254.38. See today’s analyst top recommended stocks >> Cemex SAB (CX) Berenberg Bank analyst Harry Goad maintained a Buy rating on Cemex SAB yesterday and set a price target of $10.50. The company's shares closed last Monday at $6.66. According to TipRanks.com, Goad is ranked #6682 out of 7689 analysts. Cemex SAB has an analyst consensus of Strong Buy, with a price target consensus of $10.33, a 58.4% upside from current levels. In a report released yesterday, Citigroup also upgraded the stock to Buy with a $9.30 price target. TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities. Read More on ALB: Analysts Conflicted on These Healthcare Names: Sarepta Therapeutics (SRPT), Merck & Company (MRK) and Protagonist Therapeutics (PTGX) Interfor (IFSPF) Received its Third Buy in a Row MTY Food Group (MTYFF) Receives a Hold from Scotiabank Wells Fargo Remains a Buy on American Tower (AMT) Dow Inc (DOW) Received its Third Buy in a Row